Ovarian epithelial tumors and reproductive factors: a systematic review

被引:65
作者
Schueler, Susanne [1 ]
Ponnath, Marvin [1 ]
Engel, Joerg [1 ]
Ortmann, Olaf [1 ]
机构
[1] Univ Regensburg, Caritas Hosp St Josef, D-93053 Regensburg, Germany
关键词
Epithelial ovarian tumors; Ovarian cancer; Borderline ovarian tumors; Reproductive factors; Endocrine factors; Age at menarche; Age at menopause; Parity; Infertility; PCO syndrome; Oral contraception; Menopausal hormone therapy; Fertility treatment; HORMONE REPLACEMENT THERAPY; GONADOTROPIN-RELEASING-HORMONE; ORAL-CONTRACEPTIVE USE; HUMAN CHORIONIC-GONADOTROPIN; LIFETIME OVULATORY CYCLES; GRADE SEROUS CARCINOMA; STATES CASE-CONTROL; CANCER CELL-LINE; RISK-FACTORS; GROWTH-FACTOR;
D O I
10.1007/s00404-013-2784-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose The aim of this systematic review is to summarize the current knowledge about the etiology and pathogenesis of borderline tumors ovarian cancer with special emphasis on the role of endocrine treatments and reproductive factors to establish a foundation for future studies. Methods We performed a systematic review on the relation between ovarian epithelial tumors (OET) and reproductive factors using the keywords: ovarian cancer, ovarian tumor, ovarian borderline tumor, age at menarche, age at menopause, parity, infertility, PCO syndrome, oral contraception, menopausal hormone therapy, fertility treatment. Totally, 3,290 abstracts were scanned for their relevance in this publication and 127 were finally included. Results The incidence of ovarian epithelial cancer and ovarian borderline tumors is influenced by certain reproductive factors. The strongest protective effects are conferred by parity and use of oral contraceptive pills. Recent molecular biologic and histopathologic studies prove that OET represent a diverse group of tumors, each histologic type with a different genetic background. This is at least partly reflected in epidemiologic and clinical studies showing different risk modulating effects of reproductive factors and endocrine therapies on OET. Conclusions The etiology and pathogenesis of ovarian cancer are still not fully understood. None of the so far proposed hypothesis on the development of OET can fully account for the epidemiologic and clinical findings in the context of reproductive factors and OET development. Further research approaches are warranted and need to put more weight on the clinical and genetical diversity of OET to yield a more detailed insight into their pathogenesis.
引用
收藏
页码:1187 / 1204
页数:18
相关论文
共 251 条
  • [1] Estrogen receptor expression is a common feature of ovarian borderline tumors
    AbuJawdeh, GM
    Jacobs, TW
    Niloff, J
    Cannistra, SA
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 60 (02) : 301 - 307
  • [2] PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER
    ADAMI, HO
    HSIEH, CC
    LAMBE, M
    TRICHOPOULOS, D
    LEON, D
    PERSSON, I
    EKBOM, A
    JANSON, PO
    [J]. LANCET, 1994, 344 (8932) : 1250 - 1254
  • [3] Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
    Ahmed, Ashour Ahmed
    Etemadmoghadam, Dariush
    Temple, Jillian
    Lynch, Andy G.
    Riad, Mohamed
    Sharma, Raghwa
    Stewart, Colin
    Fereday, Sian
    Caldas, Carlos
    DeFazio, Anna
    Bowtell, David
    Brenton, James D.
    [J]. JOURNAL OF PATHOLOGY, 2010, 221 (01) : 49 - 56
  • [4] Reproductive factors and incidence of epithelial ovarian cancer: A Norwegian prospective study
    Albrektsen, G
    Heuch, I
    Kvale, G
    [J]. CANCER CAUSES & CONTROL, 1996, 7 (04) : 421 - 427
  • [5] Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO
  • [6] 2-L
  • [7] Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial
    Anderson, GL
    Judd, HL
    Kaunitz, AM
    Barad, DH
    Beresford, SAA
    Pettinger, M
    Liu, J
    McNeeley, SG
    Lopez, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1739 - 1748
  • [8] Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
    Anglesio, Michael S.
    Arnold, Jeremy M.
    George, Joshy
    Tinker, Anna V.
    Tothill, Richard
    Waddell, Nic
    Simms, Lisa
    Locandro, Bianca
    Fereday, Sian
    Traficante, Nadia
    Russell, Peter
    Sharma, Raghwa
    Birrer, Michael J.
    deFazio, Anna
    Chenevix-Trench, Georgia
    Bowtelll, David D. L.
    [J]. MOLECULAR CANCER RESEARCH, 2008, 6 (11) : 1678 - 1690
  • [9] Bai WL, 2000, IN VITRO CELL DEV-AN, V36, P657
  • [10] PITUITARY-OVARIAN RELATIONSHIPS IN POLYCYSTIC OVARY SYNDROME
    BAIRD, DT
    CORKER, CS
    DAVIDSON, DW
    HUNTER, WM
    MICHIE, EA
    VANLOOK, PF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (04) : 798 - 809